FinDogFinDog
Wednesday, September 16, 2026Closing data · 4:00 PM ET
English
Log in

BMY

Bristol Myers SquibbNYSE · Pharmaceuticals · Health Care
Previous close
63.60
Change
−0.13 / −0.20%
FinDog View
Neutral
52-Week Range
42.52 – 68.64
P/E (TTM)
14.0
Forward P/E
10.4
Based on consensus earnings for the next 12 months
Market Cap
$130B
1M
−1.59%
S&P 500 −2.41% over same period
Volume / Avg Volume
9.4M / 7.5M
1.26× average

Price History

Closing price · USD1M6M1Y5Y
5055606570FY26 Q2 EarningsFY26 Q1 Earnings2026-032026-052026-062026-082026-09

Historical P/E

Close ÷ trailing four-quarter EPS · Period median 16.41M6M1Y5Y
141618202026-032026-052026-062026-082026-09

Recent Earnings

Click to read the FinDog analysis
PeriodReportedRevenueEPS Actual / Est.Next-Day MoveAnalysis
FY2026 Q2
Quarter ended 2026-06
2026-07-30$13.0B2.04 / 1.60+0.69%Read analysis →
FY2026 Q1
Quarter ended 2026-03
2026-04-30$11.5B1.58 / 1.43−3.91%Pending
FY2025 Q4
Quarter ended 2025-12
2026-02-05—— / —+4.15%Pending
FY2025 Q3
Quarter ended 2025-09
2025-10-30$12.2B1.63 / 1.52+0.99%Pending
FY2025 Q2
Quarter ended 2025-06
2025-07-31—— / —+2.12%Pending
FY2025 Q1
Quarter ended 2025-03
2025-04-24$11.2B1.80 / —−1.62%Pending

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data
Valuation
P/E is at percentile 26 of its 5-year rangeCheap
5-year range 12.4 – 19.0 · Median 16.5
Last 4 quarters: $0 in buybacks + $5.1B in dividends, 3.92% of market cap combined
P/E (TTM)
14.0
P/B
5.8
P/S
2.7
Dividend Yield
4.58%
Earnings Reaction
Over the last 6 reports, the stock moved ±2.2% on average on the first trading day after, rising 4 times
Most recent +0.69%
Volatility & Correlation
1-year beta 0.22 · Correlation with S&P 500 0.11Low beta
Annualized volatility 28% vs. 14% for the S&P 500
Insider Trading
View all →
Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 2 · $0.44MNet selling $0.44M
  • 09-09Massacesi CristianEVP,Chief Med Offr,Head of DevSell$0.40M6,249 shares · Avg price 64.57
  • 08-25Holzer Phil MSVP and ControllerSell$0.03M500 shares · Avg price 67.50
Multi-Quarter Financial Trends
View all quarters →
Last 12 quarters · As reported by the company
QuarterRevenue ($B)YoYGross MarginOperating Income ($B)Net Income ($B)Free Cash Flow ($B)EPS
FY2026 Q212.97+5.7%71.3%—3.323.091.62
FY2026 Q111.49+2.6%70.2%—2.680.761.31
FY2025 Q412.50+1.3%67.2%—1.091.600.54
FY2025 Q312.22+2.8%71.9%—2.205.991.08
FY2025 Q212.27+0.6%72.5%—1.313.560.64
FY2025 Q111.20−5.6%72.9%—2.461.691.20
FY2024 Q412.34+7.5%61.0%—0.074.060.05
FY2024 Q311.89+8.4%75.1%—1.215.270.60
FY2024 Q212.20+8.7%73.2%—1.682.060.83
FY2024 Q111.87+4.7%75.3%—-11.912.55-5.89
FY2023 Q411.48+0.6%76.1%—1.763.920.87
FY2023 Q310.97−2.2%77.1%—1.934.410.93

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →
TickerCompanyMarket CapP/ERevenue YoYGross Margin1MView
BMYBristol Myers Squibb$130B14.0+5.7%71.3%−1.59%Neutral
LLYLilly (Eli)$1.07T39.9+47.7%85.8%−3.83%BullishCompare
JNJJohnson & Johnson$644B30.6+6.6%68.2%+1.87%BullishCompare
ABBVAbbVie$464B73.7+10.2%74.7%+4.87%NeutralCompare
MRKMerck & Co.$358B112.2+5.1%73.5%+6.57%NeutralCompare
UNHUnitedHealth Group$337B23.9+0.4%88.1%−5.15%NeutralCompare
TMOThermo Fisher Scientific$240B34.4+10.5%—+10.75%BullishCompare
AMGNAmgen$203B23.3+9.5%72.0%−10.26%NeutralCompare
GILDGilead Sciences$183B—+10.2%79.8%+6.31%NeutralCompare